Abstract：
BACKGROUND:Lung cancer patients with an activating mutation in the EGFR (epidermal growth factor receptor) can develop resistance to erlotinib treatment, which is often mediated by the T790M resistance mutation in EGFR. The difficulties in obtaining biopsies at progression make it challenging to investigate the appearance of the T790M mutation at progression in large patient cohorts. We have used cell free DNA (cfDNA) from patients treated with erlotinib to investigate if the development of a T790M mutation coincides with the presence of an activating EGFR mutation in the pre-treatment blood sample. METHODS:A cohort of 227 NSCLC (non-small cell lung cancer) adenocarcinoma patients was treated with erlotinib irrespective of EGFR-mutational status. Blood samples were drawn immediately before erlotinib treatment was initiated and again at progression. The cobas® EGFR Mutation Test v2 designed for cfDNA was used to identify 42 EGFR mutations. RESULTS:Of the 227 NSCLC patients, blood samples were available from 144 patients both before erlotinib treatment and at progression (within 1 month before or after clinical progression). One hundred and twenty-eight of the 144 were wild-type EGFR before treatment, and we demonstrate that the T790M mutation was not present at progression in any of these. In contrast, in the 16 patients with an activating EGFR mutation in the pre-treatment blood sample six patients (38%) were identified with a T790M mutation in the progression blood sample. CONCLUSION:The T790M resistance mutation is only found in the cfDNA of erlotinib-treated NSCLC patients if they have an activating EGFR mutation before treatment.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Demuth C,Madsen AT,Weber B,Wu L,Meldgaard P,Sorensen BSdoi
10.1186/s12885-018-4108-0subject
Has Abstractpub_date
2018-02-15 00:00:00pages
191issue
1issn
1471-2407pii
10.1186/s12885-018-4108-0journal_volume
18pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:SPINK4 is known as a gastrointestinal peptide in the gastrointestinal tract and is abundantly expressed in human goblet cells. The clinical significance of SPINK4 in colorectal cancer (CRC) is largely unknown. METHODS:We retrieved the expression data of 1168 CRC patients from 3 Gene Expression Omnibus (GEO)...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6484-5
更新日期：2019-12-30 00:00:00
abstract：BACKGROUND:B7-H4, a co-inhibitory molecule of the B7 family, can restrain T cell proliferation, cytokine secretion and the development of cytotoxicity. B7-H4 is expressed in tumor tissues at a higher level than in normal tissues, and has a potential effect to protect tumors from anti-tumor immune responses. This case-c...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-394
更新日期：2009-11-11 00:00:00
abstract：BACKGROUND:The origin and development of breast cancer remain complex and obscure. Recently, microRNA (miRNA) has been identified as an important regulator of the initiation and progression of breast cancer, and some studies have shown the essential role of miR-124-3p as a tumor suppressor in breast tumorigenesis. Howe...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2862-4
更新日期：2016-11-15 00:00:00
abstract：BACKGROUND:Primary angiosarcomas of the right atrium are extremely rare, often resulted in missed diagnosis or misdiagnosis with routine examination tools. These malignant cardiac tumors are highly aggressive with generally poor prognosis. Surgical excision is the mainstay of treatment as it is essentially not responsi...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6450-2
更新日期：2020-01-06 00:00:00
abstract：BACKGROUND:Advanced biliary tract carcinomas (BTCs) have poor prognosis and limited therapeutic options. Therefore, it is crucial to combine standard therapies with molecular targeting. In this study EGFR, HER2, and their molecular transducers were analysed in terms of mutations, amplifications and over-expression in a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-631
更新日期：2010-11-18 00:00:00
abstract：BACKGROUND:Increased hemostatic activity is common in many cancer types and often causes additional complications and even death. Circumstantial evidence suggests that tissue factor pathway inhibitor-1 (TFPI) plays a role in cancer development. We recently reported that downregulation of TFPI inhibited apoptosis in a b...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-357
更新日期：2011-08-17 00:00:00
abstract：BACKGROUND:Randomized controlled trials have established concurrent chemo-radiotherapy as the preferred treatment option for inoperable local-regionally advanced head and neck squamous cell carcinomas (HNSCCs). Because many patients have multiple co-morbidities and would not fulfill the eligibility criteria of clinical...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-610
更新日期：2013-12-27 00:00:00
abstract：BACKGROUND:Art therapy may improve the physical, mental, and emotional wellbeing of individuals for a variety of purposes. It remains understudied and underutilized in cancer care. We sought to determine the ability of a pilot art therapy program to improve the physical, mental, and emotional well-being of cancer patie...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07380-5
更新日期：2020-09-22 00:00:00
abstract：BACKGROUND:To access the prognostic significance of HER-2 overexpression, the effect of trastuzumab and the cause of death in patients with brain metastases (BM) from breast cancer (BC). METHODS:We analyzed the outcome of 130 patients with BM from BC who received whole-brain radiotherapy (WBRT) (without surgery or rad...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-395
更新日期：2011-09-19 00:00:00
abstract：BACKGROUND:Patients with cancer of unknown primary account for 10% of patients with metastatic spinal cord compression (MSCC). This retrospective study was performed to identify prognostic factors for functional outcome, local control of MSCC, and survival in 175 of such patients treated with radiotherapy alone. METHO...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-261
更新日期：2012-06-21 00:00:00
abstract：BACKGROUND:Epidemiological studies show that cigarette smoking increase the risk of nasopharyngeal carcinoma (NPC), however, whether other common, potentially adverse household inhalants increase NPC risk remains uncertain. METHODS:We conducted a large case-control study to explore the effects of household inhalants, ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-2035-x
更新日期：2015-12-29 00:00:00
abstract：BACKGROUND:Deaf people represent 0.1% of the French population and their access to public health campaigns is limited due to their frequent illiteracy and the infrequent use of sign language in campaigns. There is also a lack of general health knowledge in spite of the existence of French Deaf Care Units (UASS). The ai...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3972-3
更新日期：2018-01-23 00:00:00
abstract：BACKGROUND:Previous data from our laboratory has indicated that there is a functional link between the beta-adrenergic receptor signaling pathway and the G-protein inwardly rectifying potassium channel (GIRK1) in human breast cancer cell lines. We wanted to determine if GIRK channels were expressed in lung cancers and ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-5-104
更新日期：2005-08-18 00:00:00
abstract：BACKGROUND:Hyponatraemia is a common finding in patients with cancer, and has been shown to be associated with poor prognosis in different settings. We have analysed the impact of severe hyponatraemia in patients with cancer. METHODS:A retrospective review of all patients admitted to a specialist cancer hospital with ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1156-6
更新日期：2015-03-22 00:00:00
abstract：:Recently, Shu-Yu Tai et al. reported that personal hair dye use increased risk of prostate cancer with a dose-response effect. Although hair dyes were identified as carcinogenic in animals and increased risk of some cancers among hairdressers, the existing epidemiological data did not support that personal hair dye us...
journal_title：BMC cancer
pub_type： 评论,杂志文章
doi：10.1186/s12885-017-3656-z
更新日期：2017-11-07 00:00:00
abstract：BACKGROUND:Survival after diagnosis is a fundamental concern in cancer epidemiology. In resource-rich settings, ambient clinical databases, municipal data and cancer registries make survival estimation in real-world populations relatively straightforward. In resource-poor settings, given the deficiencies in a variety o...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2080-0
更新日期：2016-02-06 00:00:00
abstract：BACKGROUND:"Biomarker-driven targeted therapy," the practice of tailoring patients' treatment to the expression/activity levels of disease-specific genes/proteins, remains challenging. For example, while the anti-ERBB2 monoclonal antibody, trastuzumab, was first developed using well-characterized, diverse in vitro brea...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2232-2
更新日期：2016-03-09 00:00:00
abstract：BACKGROUND:CD26/dipeptidyl peptidase IV (DPPIV) is a multifunctional membrane protein with a key role in T-cell biology and also serves as a marker of aggressive cancers, including T-cell malignancies. METHODS:Versican expression was measured by real-time RT-PCR and Western blots. Gene silencing of versican in parenta...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-517
更新日期：2013-11-01 00:00:00
abstract：BACKGROUND:As a key gene in the immunosurveillance of cell malignancy, Cytotoxic T-lymphocyte antigen 4 (CTLA-4 is an important negative regulator of T cell activation and proliferation. The CTLA-4 +49G > A polymorphism is one of the most commonly studied polymorphisms in this gene due to its association with cancer ri...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析
doi：10.1186/1471-2407-10-522
更新日期：2010-10-04 00:00:00
abstract：BACKGROUND:Deciphering the meaning of the human DNA is an outstanding goal which would revolutionize medicine and our way for treating diseases. In recent years, non-coding RNAs have attracted much attention and shown to be functional in part. Yet the importance of these RNAs especially for higher biological functions ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6338-1
更新日期：2019-12-03 00:00:00
abstract：BACKGROUND:To characterize prognostic and risk factors of central nervous system (CNS) metastases in patients with epithelial ovarian cancer (EOC). METHODS:A retrospective analysis of Xijing Hospital electronic medical records was conducted to identify patients with pathologically confirmed EOC and CNS metastases. In ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-829
更新日期：2014-11-17 00:00:00
abstract：BACKGROUND:Spontaneous regression/complete resistance (SR/CR) mice are a unique colony of mice that possess an inheritable, natural cancer resistance mediated primarily by innate cellular immunity. This resistance is effective against sarcoma 180 (S180) at exceptionally high doses and these mice remain healthy. METHOD...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-179
更新日期：2010-05-03 00:00:00
abstract：BACKGROUND:Adjuvant endocrine therapy can improve disease-free survival and time before recurrence in breast cancer patients. However, it is associated with considerable side effects that negatively affect patients' quality of life and cause non-adherence. The recently demonstrated effect of individual expectations on ...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章,随机对照试验
doi：10.1186/1471-2407-13-426
更新日期：2013-09-18 00:00:00
abstract：BACKGROUND:The clinical implication of Ras/Raf/ERK pathway activity in breast cancer tissue and its association with response to chemotherapy is controversial. We aimed to explore the value of p90RSK phosphorylation, a downstram molecule of the pathway, in predicting chemotherapy response in breast cancer. METHODS:The...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-585
更新日期：2012-12-10 00:00:00
abstract：BACKGROUND:The expression of a neural crest stem cell marker, polysialic acid (polySia), and its main carrier, neural cell adhesion molecule (NCAM), have been detected in some malignant tumors with high metastatic activity and unfavorable prognosis, but the diagnostic and prognostic value of polySia-NCAM in neuroblasto...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-57
更新日期：2009-02-17 00:00:00
abstract：BACKGROUND:There is a large body of evidence which suggests that bile acids increase the risk of colon cancer and act as tumor promoters, however, the mechanism(s) of bile acids mediated tumorigenesis is not clear. Previously we showed that deoxycholic acid (DCA), a tumorogenic bile acid, and ursodeoxycholic acid (UDCA...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-219
更新日期：2006-09-01 00:00:00
abstract：BACKGROUND:Standard chemotherapy in unresectable biliary tract carcinoma (BTC) patients is based on gemcitabine combined with platinum derivatives. However, primary or acquired resistance is inevitable and no second-line chemotherapy is demonstrated to be effective. Thus, there is an urgent need to identify new alterna...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-918
更新日期：2014-12-05 00:00:00
abstract：BACKGROUND:Chromosomal and genomic aberrations are common features of human cancers. However, chromosomal numerical and structural aberrations, breakpoints and disrupted genes have yet to be identified in esophageal squamous cell carcinoma (ESCC). METHODS:Using multiplex-fluorescence in situ hybridization (M-FISH) and...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-367
更新日期：2012-08-24 00:00:00
abstract：BACKGROUND:We have recently described the correlation between quantitative measures of HER2 expression or HER2 homodimers by the HERmark assay and objective response (RR), time-to progression (TTP), and overall survival (OS) in an expanded access cohort of trastuzumab-treated HER2-positive patients with metastatic brea...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-56
更新日期：2010-02-23 00:00:00
abstract：BACKGROUND:Interleukin 12 (IL-12) is a cytokine that has been reported to exhibit potent tumoricidal effects in animal tumor models. A combined approach using Paclitaxel and platinum-based doublet chemotherapy is the most commonly used backbone regimen for treating lung cancer. Despite numerous studies regarding the an...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2701-7
更新日期：2016-08-22 00:00:00
